Medicine
Liothyronine 10 mcg/1 mL injection
Liothyronine 10 mcg/1 mL injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store between 2°C – 8°C (36°F – 46°F).
Key facts
- Active ingredient (INN)
- Liothyronine
- Brand
- Sold under the generic name
- Strength
- 10 mcg/1 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 vial of 1 mL
- Manufacturer
- XGen Pharmaceuticals DJB
- Origin register
- US FDA, United States
- Storage
- Store between 2°C – 8°C (36°F – 46°F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 17 August 2005
- Identifiers
- DailyMed set ID a8b39730-de19-497d-bde8-6594aa528403NDC 39822-0151Application ANDA076923
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial in 1 carton / 1 mL in 1 vial | 39822-0151-1 | XGen Pharmaceuticals DJB | 17 August 2005 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 8 May 1956 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Liothyronine
Clinical summary
Liothyronine is a l-triiodothyronine indicated for hypothyroidism, among other approved uses. It is available as tablets and injection for oral and intravenous use. MedsAcross supplies Liothyronine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LiothyronineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Liothyronine Sodium prescribing information (Mylan Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Liothyronine 10 mcg/1 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.